Читать «Трещина в мироздании» онлайн - страница 196

Y. Anwar, “UC Berkeley to Partner in $ 600M Chan Zuckerberg Science ‘Biohub,’” Berkeley News, September 21, 2016.

199

R. Sanders, “New DNA-Editing Technology Spawns Bold UC Initiative”, Berkeley News, March 18, 2014.

200

Y. Wu et al., “Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9”, Cell Stem Cell 13 (2013): 659–662.

201

K. Allers and T. Schneider, “CCR5Δ32 Mutation and HIV Infection: Basis for Curative HIV Therapy”, Current Opinion in Virology 14 (2015): 24–29.

202

S. G. Deeks and J. M. McCune, “Can HIV Be Cured with Stem Cell Therapy?”, Nature Biotechnology 28 (2010): 807–810.

203

W. G. Glass et al., “CCR5 Deficiency Increases Risk of Symptomatic West Nile Virus Infection”, Journal of Experimental Medicine 203 (2006): 35–40.

204

P. Tebas et al., “Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV”, New England Journal of Medicine 370 (2014): 901–910.

205

Там же.

206

N. Wade, “Gene Editing Offers Hope for Treating Duchenne Muscular Dystrophy, Studies Find”, New York Times, December 31, 2015.

207

H. Yin et al., “Therapeutic Genome Editing by Combined Viral and Non-Viral Delivery of CRISPR System Components in Vivo”, Nature Biotechnology 34 (2016): 328–333.

208

X. Chen and M. A. F. V. GonÇalves, “Engineered Viruses as Genome Editing Devices”, Molecular Therapy 24 (2015): 447–457.

209

American Cancer Society, Cancer Facts and Figures 2016 (Atlanta: American Cancer Society, 2016).

210

D. Heckl et al., “Generation of Mouse Models of Myeloid Malignancy with Combinatorial Genetic Lesions Using CRISPR-Cas9 Genome Editing”, Nature Biotechnology 32 (2014): 941–946.

211

В рамках русскоязычной медицинской терминологии лейкоз нельзя называть раком. В узком смысле слова рак – это злокачественная опухоль эпителиального происхождения, а клетки крови к эпителию не относятся.

212

T. Wang et al., “Identification and Characterization of Essential Genes in the Human Genome”, Science 350 (2015): 1096–1101.

213

S. Begley, “Medical First: Gene-Editing Tool Used to Treat Girl’s Cancer”, STAT News, November 5, 2015; A. Pollack, “A Cell Therapy Untested in Humans Saves a Baby with Cancer”, New York Times, November 5, 2015.

214

W. Qasim et al., “First Clinical Application of TALEN Engineered Universal CAR19 T Cells in B-ALL”, статья, представленная на ежегодной встрече Американского общества гематологов, Орландо, Флорида, 5–8 декабря 2015-го.

215

D. Cyranoski, “CRISPR Gene-Editing Tested in a Person for the First Time”, Nature News, November 15, 2016.

216

M. Jinek et al., “A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity”, Science 337 (2012): 816–821.

217

V. Pattanayak et al., “High-Throughput Profiling of Off-Target DNA Cleavage Reveals RNA-Programmed Cas9 Nuclease Specificity”, Nature Biotechnology 31 (2013): 839–843.

218

Y. Fu et al., “High-Frequency Off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells”, Nature Biotechnology 31 (2013): 822–826; P. D. Hsu et al., “DNA Targeting Specificity of RNA-Guided Cas9 Nucleases”, Nature Biotechnology 31 (2013): 827–832.